Cargando…
Optimizing the Use of Current Treatments and Emerging Therapeutic Approaches to Achieve Therapeutic Success in Patients with Inflammatory Bowel Disease
The current goal of inflammatory bowel disease (IBD) treatment is a symptom-free everyday life accompanied by mucosal healing with minimal use of corticosteroids. Recent therapeutic advances, particularly, the emergence of anti-tumor necrosis factor (anti-TNF) antibodies, have changed the natural hi...
Autor principal: | Nakase, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974326/ https://www.ncbi.nlm.nih.gov/pubmed/30919602 http://dx.doi.org/10.5009/gnl18203 |
Ejemplares similares
-
Emerging therapeutic options in inflammatory bowel disease
por: Yamamoto-Furusho, Jesus K, et al.
Publicado: (2021) -
Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments
por: Lee, Scott D., et al.
Publicado: (2021) -
The microbiota in inflammatory bowel disease: current and therapeutic insights
por: Lane, Erin R, et al.
Publicado: (2017) -
Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease
por: Wagatsuma, Kohei, et al.
Publicado: (2021) -
Endoscopic Therapeutic Approach for Dysplasia in Inflammatory Bowel Disease
por: Hong, Sung Noh
Publicado: (2017)